Krystal Biotech is trading 4.2% down at $355.55 today amid potential profit-taking following a strong multi-month rally.
- No fresh company-specific news or major analyst calls have emerged this morning to explain the downward move.
- The decline contrasts with slightly positive broader market indices, suggesting technical trading or a cooling off period rather than a shift in fundamental developments.